Temasek

Temasek's arm Ramon gets CCI's approval to acquire stake in Speed JVco

The Competition Commission of India (CCI) on Tuesday said it has cleared Ramon Investments Pte's, an arm of Temasek Holdings, a proposal to acquire a stake in Speed JVco. Singapore-headquartered Temasek is an investment company. As of March 2024, the sovereign wealth fund owns a Singapore Dollar (SGD) 389 billion portfolio of assets. "The proposed combination involves the acquisition of a certain stake of the target (Speed JVco) by the acquirer (Ramon Investments Pte Ltd)," CCI said in a release. Speed JVco, including its affiliates, provides visa outsourcing and related services -- offering visa application and consular services to governments and diplomatic missions. The company also provides travel-related services, including facilitation of travel itineraries and hotel reservations, facilitation of travel insurance and other ancillary services, such as providing sim cards and forex, among others. "Commission approves the acquisition of certain stake of Speed JVco S.a r.l. (Tar

IPO-bound Rebel Foods raises $210 million in funding round led by Temasek

Other participants included existing investor Evolvence. The Series G round which was a mix of primary and secondary share sales also facilitated exits for certain investors, the company said

Singapore's Temasek establishes $7.5 billion private credit entity

Institutional global investors in recent years have been ramping up activity in the booming private credit market

Fidelity increases IPO-bound Lenskart valuation by 12% to $5.6 billion

This year, IPO-bound Lenskart raised $200 million in secondary investment from Singapore's state-owned investment firm Temasek and Fidelity

Donald Trump's victory in US elections would slow global growth: Temasek

Sipahimalani said that while a Harris win would be beneficial for emerging markets, the opposite is likely under a Trump victory

Temasek invests $60m in Upgrad, valuation holds steady at $2.25 billion

Singapore's Temasek invests $60 million in Upgrad, maintaining a $2.25B valuation, while founder Ronnie Screwvala increases his stake to 45 per cent amid strategic changes for growth

Temasek's Fullerton picks up controlling stake in Lendingkart for Rs 252 cr

The fintech company plans to deepen its reach in underserved markets and improve its technology with the latest capital infusion

Temasek in talks to pick minority stake in Haldiram's at $11 bn valuation

The Singapore state investor is holding preliminary talks to buy from 10 per cent to 15 per cent in Haldiram's

Temasek's arm cuts off 1.4% stake in Godrej Agrovet for over Rs 212 cr

V-Sciences Investments, an arm of Temasek Holdings, on Friday divested a 1.4 per cent stake in Godrej Agrovet for more than Rs 212 crore through an open market transaction. Temasek Holdings is a state-owned multinational investment firm in Singapore. As of March 31, 2024, the investment company held an SGD 389 billion of portfolio value. According to the bulk deal data available on the National Stock Exchange (NSE), V-Sciences Investments offloaded 27.10 lakh shares, or 1.41 per cent stake, in Godrej Agrovet. The shares were disposed of at an average price of Rs 785.13 apiece, taking the deal value to Rs 212.77 crore. After the stake sale, V-Sciences Investments' holding in Godrej Agrovet has declined to 6.36 per cent from 7.77 per cent. Details of buyers of Godrej Agrovet's shares could not be identified. In May 2022, Temasek trimmed its stake by selling 40 lakh shares of agri firm Godrej Agrovet for Rs 197 crore. Prior to that, the Singaporean global investment company in Febru

'Temasek's focus in India will be minority stakes, growth investing'

India now accounts for about 7% of Temasek's net portfolio value of S$389 billion ($289 billion), up from 4% in 2020, Shrivastav said.

Temasek likely to invest $10 billion in India in the next three years

Singapore firm's exposure in country likely to touch $47 bn in 3 years

Temasek investments in Americas cross bets on China first time in decade

It is also planning to increase its bets on India, which accounted for 7% of its portfolio in March

Warburg, Temasek & JP Morgan sell 13.7% stake in CarTrade for Rs 535 cr

Warburg Pincus, Temasek Holdings and JP Morgan Investment on Monday divested a total of 13 per cent stake in CarTrade Tech for Rs 535 crore through open market transactions. Highdell Investment, an arm of US-based Warburg Pincus, sold the shares of CarTrade Tech while Singapore's sovereign wealth fund Temasek Holdings' affiliate MacRitchie Investments offloaded shares of the company on the BSE. CMDB II, a private equity fund run by JP Morgan Investment Management also sold the shares of CarTrade Tech through a bulk deal on the National Stock Exchange (NSE). A total of 64.57 lakh shares or 13.77 per cent stake were pared by Warburg Pincus, Temasek and JP Morgan. According to the bulk deal data available on the BSE, Highdell Investment sold 40.65 lakh shares, amounting to an 8.66 per cent stake in CarTrade Tech. MacRitchie Investments sold 20.32 lakh shares or 4.33 per cent stake in Mumbai-based CarTrade Tech. The shares were sold in the price range of Rs 828-828.58 apiece by the tw

Molbio Diagnostics prepares for IPO in FY25 to raise Rs 2,200-2,400 crore

Molbio Diagnostics became Goa's first startup to achieve unicorn status in September 2022 following a Rs 680 crore investment from Temasek and MOPE, plans to launch the IPO in November

Tata Sons raises stake in Tata Play to 70% as Temasek exits: Report

Tata Play has informed the Ministry of Information and Broadcasting about the change in shareholding

Buyouts help Temasek-backed firm Manipal Health vie for top spot in India

Local news website MoneyControl reported earlier this week that Manipal was in the final leg of discussions to acquire Kolkata-based Medica Synergie, which will bring in 1,200 beds.

M&As register huge drop in 2023, overall deal values halve to $66 billion

Deal values in India more than halved in 2023 to USD 66 billion despite high growth, as investors took a wait-and-watch approach, a report said on Friday. From a volume perspective, there were 1,641 deals -- a drop of more than 20 per cent over 2022 -- the report by consultancy firm Grant Thornton Bharat said. The firm's partner Shanthi Vijetha said lack of liquidity in international markets, volatile market conditions, and cautious investor sentiment hindered deal activities in 2023. "As India's emphasis on sustainability and environmental responsibility positions it as an attractive hub for opportunities in the global economy, we must first overcome challenges such as currency strength and global instability," Vijetha added. Merger and acquisition deal values dropped 72 per cent to USD 25.2 billion across 494 transactions, impacting the overall number the most, the report said. Outbound M&As were at USD 3.2 billion -- as against USD 17.9 billion in the year-ago period -- were ..

Temasek plan to sell stake in Tata Play delayed over firm's valuation

Tata Sons is offering a lower valuation than $1 billion made for Tata Play

Space-tech company Skyroot raises $27.5 mn in funding round led by Temasek

Skyroot plans to utilise the newly acquired capital to drive its next growth phase

MO Alternates, Temasek, Paragon to invest Rs 800 crore in Niva Bupa

Health insurer Niva Bupa on Thursday said a clutch of private equity funds have committed to invest Rs 800 crore in the company. India Business Excellence Fund IV (MO Alternate Investment Advisors), Temasek and Paragon Partners Growth Fund II will be investing the money for a minority stake in the company, as per an official statement. The announcement comes within a fortnight of homegrown private equity major True North announcing a 20 per cent stake sale in the company to Bupa for Rs 2,700 crore, making the UK-headquartered company a majority owner in the company. "This latest injection of capital will play a pivotal role in propelling the company towards its long-term ambitions and strategic objectives," True North's partner Divya Sehgal said. True North had earlier said that future growth options for the company, in which it continues to hold a minority stake, could also include the public listing. The company's chief executive and managing director Krishnan Ramachandran said